FBH 001Alternative Names: CCHF (FBH-001); FBH-001
Latest Information Update: 11 Aug 2016
At a glance
- Originator Fabentech
- Developer Fabentech; INSERM; United States Army Medical Research Institute of Infectious Diseases
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Crimean-Congo haemorrhagic fever virus infections
Most Recent Events
- 22 Jul 2016 Preclinical trials in Crimean-Congo haemorrhagic fever virus infections (Prevention) in France (Parenteral)